Stockscreener 앱 받기
1.02
3.02%
0.0299
시간 외 거래:
1.01
-0.01
-0.98%
전일 마감가:
$0.9901
열려 있는:
$0.96
하루 거래량:
55,129
Relative Volume:
0.33
시가총액:
$45.42M
수익:
$63.15M
순이익/손실:
$-40.30M
주가수익비율:
-0.6108
EPS:
-1.67
순현금흐름:
$-44.47M
1주 성능:
-6.42%
1개월 성능:
-13.56%
6개월 성능:
-48.74%
1년 성능:
-61.65%
1일 변동 폭
$0.96
$1.02
1주일 범위
$0.96
$1.10
52주 변동 폭
$0.8645
$2.96
Tela Bio Inc Stock (TELA) Company Profile
명칭
Tela Bio Inc
전화
484-320-2930
주소
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
TELA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.02 | 44.09M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 개시 | Lake Street | Buy |
| 2019-12-03 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | JMP Securities | Mkt Outperform |
| 2019-12-03 | 개시 | Jefferies | Buy |
| 2019-12-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Tela Bio Inc 주식(TELA)의 최신 뉴스
Guidance Update: Whats the analyst consensus on TELA Bio Inc2025 Historical Comparison & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Volume: Why TELA Bio Inc stock is a must watch in 2025Market Trend Summary & Proven Capital Preservation Methods - Bộ Nội Vụ
Aug Setups: Will TELA Bio Inc stock outperform growth indexesJuly 2025 Recap & Low Risk High Win Rate Picks - Bộ Nội Vụ
TELA Bio Grants Inducement Stock Units to New Employees - MSN
Aug Chart Watch: Will TELA Bio Inc stock outperform growth indexesJuly 2025 Institutional & Real-Time Volume Triggers - Bộ Nội Vụ
How TELA Bio Inc. stock reacts to bond yieldsBreathability and Upper Notes & updated model highlights and notes - ulpravda.ru
Can TELA Bio Inc. stock maintain growth trajectoryTrade Analysis Report & Safe Entry Zone Tips - ulpravda.ru
Becton, Dickinson accused of hindering competition in hernia mesh market - MSN
Aug Action: How TELA Bio Inc. stock compares to growth peersQuarterly Profit Report & Community Verified Trade Signals - Улправда
Is TELA Bio Inc. stock in correction or buying zoneStock Market Trends & Build Winning Strategies With Zero Cost - ulpravda.ru
TELA Bio introduces LIQUIFIX for enhanced surgical precision - Traders Union
TELA Bio to Present at Canaccord Genuity 45th Annual Growth Conference - MSN
TELA Bio Appoints Healthcare Leader Betty Jo Rocchio to Board of Directors - MSN
Is It Too Late to Sell PVV Infra LimitedLong-Term Investment Plans & Outstanding Wealth Building - earlytimes.in
TELA Bio Inc Stock Analysis and ForecastVolatility Trading Techniques & Minimal Investment Profits - earlytimes.in
Movement Recap: How TELA Bio Inc stock reacts to bond yieldsJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - moha.gov.vn
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Benzinga
Tela Bio sues BD over hernia mesh monopoly claims - Fierce Biotech
Becton Muscles Out Hernia Mesh Rivals, Antitrust Suit Says - Law360
Tela Bio (TELA) Sues Becton, Dickinson Over Hernia Mesh Market P - GuruFocus
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters
Is TELA Bio Inc. stock a top pick in earnings seasonWeekly Market Outlook & Smart Swing Trading Techniques - Улправда
How sustainable is TELA Bio Inc. stock dividend payoutQuarterly Portfolio Summary & Growth Focused Entry Point Reports - Улправда
Will TELA Bio Inc. stock continue dividend increasesWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
Becton Dickinson Faces Antitrust Suit Over Hernia Mesh Products - Bloomberg Law News
Whale Trades: Is TELA Bio Inc. stock a top pick in earnings seasonMarket Growth Review & Daily Stock Trend Watchlist - Улправда
Update Report: Is TELA Bio Inc. stock gaining market shareJuly 2025 Opening Moves & Safe Entry Momentum Tips - ulpravda.ru
TELA Bio signals growth with new-hire equity grants - MSN
Is TELA Bio Inc. stock gaining market shareTrade Volume Report & Risk Managed Investment Signals - Улправда
Canaccord Genuity Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
TELA Bio Signals Growth With New-Hire Equity Grants - MyChesCo
TELA Bio Earnings Notes - Trefis
TELA Bio (TELA) price target decreased by 25.81% to 3.52 - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Associated Press | syndication news - Enidnews.com
What analysts say about TELA Bio Inc stockTrading Volume Surges & High Return Capital Growth - earlytimes.in
TELA Bio, Inc. (NASDAQ:TELA) Receives $3.25 Consensus Price Target from Analysts - Defense World
Resistance Check: Is TELA Bio Inc stock gaining market shareMarket Performance Summary & Entry Point Strategy Guides - BỘ NỘI VỤ
TELA Bio (TELA) Stock Analysis Report | Financials & Insights - Benzinga
Adamas Trust, Inc. Announces Pricing of Public Offering of Senior Notes - The Globe and Mail
TELA Bio stock price target lowered to $3 by Lake Street on sales issues - Investing.com South Africa
Lake Street Maintains TELA Bio (TELA) Buy Recommendation - Nasdaq
Lake Street Lowers Price Target for TELA Bio (TELA) Amid Continued Buy Rating | TELA Stock News - GuruFocus
TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
TELA Bio Set to Spotlight Soft-Tissue Innovations at Major Healthcare Conference - MSN
TELA Bio Unveils New Wave of Hiring With Stock Grants Tied to Growth Push - MSN
Tela Bio Inc (TELA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):